News & Press | Boxer Lab

March 24th, 2021

FTD Trials: The Now and the Future

ALZFORUM

March 23rd, 2021

Cohorts Band Together to Get Global FTD Trials Going

ALZFORUM

March 16th, 2021

FTD Fluid Markers for Degeneration: Check. For Pathology: Not Yet.

ALFORUM

March 13th, 2021

Merged Consortia Forge Path to Trials in Frontotemporal Dementia

ALZFORUM

February 4th, 2021

Detecting Alzheimer’s Gets Easier with a Simple Blood Test

Scientific American

March 26th, 2019

Retired neurologist with Alzheimer's shares importance of early awareness

KATU News

March 21st, 2019

Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of Aducanumab in AD

Biogen

February 18th, 2019

Early Awareness of Alzheimer Disease A Neurologist’s Personal Perspective

JAMA Neurology. 2019;76(3):249. © 2019 American Medical Association. All rights reserved.

January 30th, 2019

Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early AD

Roche

December 27th, 2018

Rainwater family seeks cure to billionaire's brain disease

The Washington Times

December 15th, 2017

At Least We Know These Don't Work: Negative Trials at CTAD

Alzforum

December 13th, 2017

Research Update: Clinical Drug Trials

UCSF Memory and Aging Center